Feifei An
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 5%
Papers in
- Biomaterials 19
- Nanoparticle-Based Drug Delivery 18
-
- Nanoplatforms for cancer theranostics 33
- Co-authors
- Xiao‐Hong Zhang (20 shared papers)Ömer Aras (15 shared papers)Jinfeng Zhang (8 shared papers)Chun‐Sing Lee (8 shared papers)Jingqi Xin (12 shared papers)Mengjiao Zhou (8 shared papers)Caiting Deng (13 shared papers)Xing‐Jie Liang (4 shared papers)
- Journals
- Chinese Chemical Letters (5 papers)Small (3 papers)Journal of Materials Chemistry B (3 papers)ACS Applied Materials & Interfaces (3 papers)Journal of Nanobiotechnology (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Feifei An
64 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 83
- Biomaterials 843
- Drug Discovery 16
- Biomedical Engineering 901
- Pharmaceutical Science 106
- Molecular Medicine 83
Countries citing papers authored by Feifei An
This map shows the geographic impact of Feifei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei An more than expected).
Fields of papers citing papers by Feifei An
This network shows the impact of papers produced by Feifei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei An. The network helps show where Feifei An may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 393 | |
| 2 | 2014 | 166 | |
| 3 | 2015 | 163 | |
| 4 | 2021 | 101 | |
| 5 | 2023 | 91 | |
| 6 | 2014 | 87 | |
| 7 | 2019 | 87 | |
| 8 | 2020 | 87 | |
| 9 | 2022 | 85 | |
| 10 | 2018 | 78 | |
| 11 | 2012 | 74 | |
| 12 | 2012 | 65 | |
| 13 | 2021 | 65 | |
| 14 | 2020 | 56 | |
| 15 | 2020 | 55 | |
| 16 | 2014 | 52 | |
| 17 | 2014 | 52 | |
| 18 | 2020 | 49 | |
| 19 | 2016 | 48 | |
| 20 | 2021 | 44 |
About Feifei An
Feifei An is a scholar working on Biomaterials, Biomedical Engineering, Materials Chemistry, Radiology, Nuclear Medicine and Imaging and Spectroscopy, having authored 64 papers that have together received 2.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (33 papers), Nanoparticle-Based Drug Delivery (18 papers), Luminescence and Fluorescent Materials (12 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Photodynamic Therapy Research Studies (5 papers), Molecular Sensors and Ion Detection (4 papers), Optical Imaging and Spectroscopy Techniques (3 papers) and Medical Imaging Techniques and Applications (3 papers). The work is most often cited by research in Biomaterials (843 citations), Drug Discovery (16 citations), Biomedical Engineering (901 citations), Pharmaceutical Science (106 citations) and Molecular Medicine (83 citations). Feifei An has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiao‐Hong Zhang, Ömer Aras, Jinfeng Zhang, Chun‐Sing Lee, Jingqi Xin, Mengjiao Zhou, Caiting Deng, Xing‐Jie Liang, Richard Ting and Yinlong Yang. Their work appears in journals such as Chinese Chemical Letters, Small, Journal of Materials Chemistry B, ACS Applied Materials & Interfaces and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.